Evidence map›Paper›PMID 42130839›Full record

ArticleRSC advances2026

Biological activities of metal oxide nanoparticles modified with hexadeca-substituted cobalt(ii) phthalocyanine bearing fluorinated substituents.

Nazlı Farajzadeh Öztürk

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Nazlı Farajzadeh ÖztürkFaculty of Pharmacy, Department of Analytical Chemistry, Acıbadem Mehmet Ali Aydınlar University Ataşehir TR-34752 Istanbul Turkey nazli.ozturk@acibadem.edu.tr.ORCID https://orcid.org/0000-0002-3857-5673

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recognition of the flexible structure of phthalocyanines, which can be tailored for specific applications, has attracted growing attention, as these compounds can enhance the efficiency of many technological and scientific systems. This study presents the synthesis of a new phthalonitrile derivative, namely 3,4,5,6-tetrakis(4-(trifluoromethoxy)phenoxy)phthalonitrile and its hexadeca-substituted cobalt(ii) phthalocyanine. The newly synthesized phthalocyanine was used to functionalize the surface of alumina (Al

Identifiers

PMID42130839
PMCPMC13163680

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.